Skip to main content

Find Clinical Trials

Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

Thermal Ablation of Cervical Metastases From Thyroid Carcinoma

NCT04522570

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +24 more
Locations: Instituto do Cancer do Estado de São Paulo São Paulo, Brazil

View Trial Details

Active, Not Recruiting

HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study

NCT05167071

Conditions: CRC, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Beijing Cancer Hospital Beijing, China

View Trial Details

Active, Not Recruiting

Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy

NCT03719131

Conditions: Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV, Melanoma, +17 more
Locations: Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Active, Not Recruiting

TH1902 in Patients With Advanced Solid Tumors

NCT04706962

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more
Locations: Karmanos Cancer Institute Detroit, Michigan, United States

START Midwest Grand Rapids, Michigan, United States

Pennsylvania Cancer Specialists Research Institute Gettysburg, Pennsylvania, United States

Mary Crowley Cancer Research Dallas, Texas, United States

View Trial Details

Active, Not Recruiting

Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs

NCT06014619

Conditions: Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +28 more
Locations: Maastricht University Medical Center+ Maastricht, Netherlands

View Trial Details

Active, Not Recruiting

Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)

NCT04164901

Conditions: Glioma, Grade 2 Glioma, Neoplasms, +8 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

City of Hope Duarte, California, United States

University of California San Diego La Jolla, California, United States

UCLA Oncology Center Los Angeles, California, United States

View all 84 locations

View Trial Details

Active, Not Recruiting

Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study

NCT05753995

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Kepler University Hospital Linz, Upper Austria, Austria

View Trial Details

Active, Not Recruiting

Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic)

NCT03772899

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: London Regional Cancer Program London, Ontario, Canada

CHUM Montréal, Ontario, Canada

Jewish General Hospital Montreal, Quebec, Canada

View Trial Details

Active, Not Recruiting

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

NCT04802876

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +111 more
Locations: Grupo SOLTI Barcelona, Spain

View Trial Details

Active, Not Recruiting

Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)

NCT03496402

Conditions: Central Nervous System Neoplasms, Central Nervous System Tumor, Ewing Sarcoma Family of Tumors, +24 more
Locations: Chu D'Amiens Picardie Amiens, France

CHU Angers Angers, France

CHRU de Besançon - Hôpital Jean-Minjoz Besançon, France

CHU de Bordeaux - Hôpital des enfants - Groupe Hospitalier Pellegrin Bordeaux, France

View all 30 locations

View Trial Details